Perspective technologies in vaccination and immunotherapy

October 5-8, 2018

 
 



      



Baltic Vaccine Network


View the final program of the conference 



View the program of the Satellite symposium

Members:

ORGANIZING COMMITTEE

Co-chairs:
- Isaguliants Maria, PhD, Assoc Prof, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Gamaleja Research Center of Epidemiology, and Microbiology, Moscow, Russia; Karolinska Institutet, Stockholm, Sweden; Riga Stradins University, Riga, Latvia
- Gordeychuk Ilya, PhD, Docent, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Gamaleja Research Center of Epidemiology, and Microbiology, and Sechenov 1st Moscow State Medical University, Moscow, Russia

1. Abakumov Maxim, Gamaleja Research Center of Epidemiology, and Microbiology, and Pirogov Russian National Research Medical University, Moscow, Russia
2. Afanasieva Ekaterina, meeting management company “Monomax”, St. Petersburg, Russia
3. Oleg Latyshev, Gamaleja Research Center of Epidemiology, and Microbiology, Moscow, Russia 
4. Lutaya Svetalana, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia
5. Petrakova Natalia, Gamaleja Research Center of Epidemiology, and Microbiology, Moscow, Russia
6. Sotskova Svetlana, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences, Moscow, Russia

PROGRAM COMMITTEE
1. Aparin Petr, Prof, Institute of Immunology, Federal Medical Biological Agency, Moscow, Russia
2. Buonaguro Franco, Prof, Department of Experimental Oncology, National Cancer Institute 'Fondazione Pascale', Naples, Italy
3. Egorov Alexey, Prof, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences, and Moscow State University, Moscow, Russia
4. Ishmukhametov Aydar, Prof, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia
5. Isaguliants Maria, Assoc Prof, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Gamaleja Research Center of Epidemiology, and Microbiology, Moscow, Russia; Riga Stradins University, Riga, Latvia; and Karolinska Institutet, Stockholm, Sweden
6. Karganova Galina, Prof, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences, Moscow, Russia
7. Liu Margaret, Prof, International Society for Vaccines, ProTherImmune, and UCSF, San Francisco, USA
8. Lu Shan, Prof, University of Massachusets Medical School, Worcester, USA
9. Joon Rhee, Prof, Chonnam National University Hwasun Hospital, Jeonnam, and Clinical Vaccine R&D Center, Chonnam National University, Gwangju, Republic of Korea
10. Evgeniy Tkachenko, Prof, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of Russian Academy of Sciences, Moscow, Russia
11. Britta Wahren, Prof, Karolinska Institutet, Stockholm, Sweden
12. Zverev Vitaliy, Prof, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia